Company intelligence / Profile preview

Pegasus Biologics

Irvine, California, United Statespegasusbio.com ↗

Ownership: Private
Employees: ~51
Development stage: Commercial

Overview

Pegasus Biologics developed and commercialized bioimplants such as OrthADAPT Bioimplant and Unite Biomatrix for soft tissue repair and wound care. Their products were used in orthopedics, sports medicine, neurosurgery, spine applications, and wound management. The company was acquired by Synovis Life Technologies in 2009.

Therapeutic areas: EndocrinologyRheumatology
Modalities: BioimplantCollagen scaffoldTissue scaffold
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Pegasus Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pegasus Biologics.

Explore the full profile